FDA Warns of Problems with Montana Mammography Lab Results
Federal health officials indicate that a diagnostic imaging lab in Montana may have produced poor quality mammogram results, which may raise concerns for patients examined since November 2011.
The FDA issued a safety communication on Monday, warning patients who had mammograms performed by Big Sky Diagnostic Imaging, LLC in Butte, Montana that there may be quality problems with the mammograms the lab has performed.
According to the FDA warning, the quality problems could affect any patient who had a mammogram at Big Sky Diagnostic at any time after November 19, 2011. However, the FDA stressed that the warning does not automatically mean that the examinations were inaccurate.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The agency recommends that patients who had mammograms done at the laboratory speak with their health care provider to determine if they need to get retested.
The laboratory had its accreditation revoked by the American College of Radiology (ACR) and stopped performing mammograms in February. It also no longer has a Mammography Quality Standards Act (MQSA) certificate.
The facility lost the ACR accreditation following a routine review of mammogram samples. ACR and FDA investigators determined that some mammograms from Big Sky Diagnostic Imaging taken from November 20, 2011 to November 20, 2013 failed to meet the baseline quality standards of mammograms required for a facility to operate in the United States.
Mammograms are low-dose x-ray images of the breasts used to detect breast cancer in its earliest stages. An incorrect mammogram could lead to a missed opportunity to treat breast cancer when it is at its most treatable and could negatively affect the quality of life or lifespan of the patient. Conversely, a poor quality mammogram that returns a false positive could lead to unnecessary testing and cancer treatments.
"*" indicates required fields
More Top Stories
Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.
More than 775 Exactech lawsuits have been filed in federal and state courts as parties work toward a plan for bellwether early test trials.
A federal judge has announced he will soon begin remanding 3M earplug lawsuits back to their originating districts for trials over claims of veteran hearing loss.